Search

Your search keyword '"Hadell, Karin"' showing total 3 results
Start Over Author "Hadell, Karin"
3 results on '"Hadell, Karin"'

1. The Plate Model: a visual method of teaching meal planning

Author

Camelon, Kathryn M., Hadell, Karin, Jamsen, Paivi T., Ketonen, Kaisa J., Kohtamaki, Heli M., Makimatilla, Sari, Tormala, Marja-Leena, and Valve, Raisa H.

Subjects
Cookery for diabetics -- Planning, Diabetes -- Diet therapy, Diet therapy -- Planning, Food/cooking/nutrition, Company business planning, Planning, Diet therapy
Abstract

Dietitians from Canada, Finland, France, and Sweden have explored methods of teaching meal planning to persons with diabetes and dyslipidemia in the Diabetes Atherosclerosis Intervention Study. The Plate Model, a method commonly used in Europe, is a simple alternative to the traditional exchange-based method for teaching meal planning. In this visual method, a dinner plate serves as a pie chart to show proportions of the plate that should be covered by various food groups. Portions of foods and appropriate food choices can be depicted for meals and snacks in assorted forms of the model. Methods of presenting the model range from professional photography to hand-drawn sketches and displays of food replicas. Benefits of the model for adult learners include enhancement of the connection between dietary theory and practice, promotion of memory retention and understanding through visual messages, and experience of a positive approach to nutrition counseling. Various cuisines and festive foods can be incorporated into the model. The Plate Model offers a meal planning approach that is simple and versatile. The effectiveness of the model and its applications to other populations need to be evaluated., Dietitians recognize the need to have simple methods of teaching meal planning to people with type 2 diabetes mellitus and dyslipidemia (1-5). Diet is considered a cornerstone of therapy for [...]

Published
1998

2. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST)

Author

Walldius, Goran, Erikson, Uno, Olsson, Anders G., Bergstrand, Lott, Hadell, Karin, Johansson, Jan, Kaijser, Lennart, Lassvik, Claes, Molgaard, Jorgen, Nilsson, Sven, Schafer-Elinder, Liselotte, Stenport, Goran, and Holme, Ingar

Subjects
Hypercholesterolemia -- Drug therapy, Probucol -- Evaluation, Femoral artery, Atherosclerosis, Health
Abstract

The Probucol Quantitative Regression Swedish Trial tested whether treatment of hypercholesterolemic persons with probucol for 3 years affected femoral atherosclerosis. The primary end point was the change in atheroma volume estimated as change in lumen volume of the femoral artery assessed by quantitative arteriography. Three hundred three patients with visible atherosclerosis were randomized to probucol 0.5 g, twice daily, or to placebo. All patients were given diet and cholestyramine, 8 to 16 g/day. Twenty-nine patients were excluded because of inadequate primary end point measurements. The mean age of the remaining 274 subjects (158 were men) was 55 years. Seventeen percent had intermittent claudication and 24% had angina pectoris. After 3 years, the probucol-treated patients had 17% lower serum cholesterol, 12% lower low-density lipoprotein cholesterol, 24% lower total high-density lipoprotein cholesterol, and 34% lower high-density [lipoprotein.sub.2] cholesterol levels than control subjects. All lipoprotein differences between the treatment groups remained highly significant during the trial. There was no statistically significant change in lumen volume between the probucol and the control group. Furthermore, there was no difference between the treatment groups with regard to change in arterial edge roughness or amount of aorto-femoral atherosclerosis; neither were there any differences between the treatment groups with regard to change in ST-segment depressions on exercise tests or ankle/arm blood pressure (secondary end points). In the control group, lumen volume increased (p [less than] 0.001) and roughness of the femoral artery decreased (p [less than] 0.05). It is concluded that the addition of probucol to diet and cholestyramine did not result in any significant regression of atherosclerosis compared with that found in patients treated only with diet and cholestyramine. However, in this control group there was statistically significant evidence of improvement. (Am J Cardiol 1994;74:875-883)

Published
1994

Catalog

Books, media, physical & digital resources
See catalog results